A new booklet to provide NHS executives and managers with information about the ABPI Code of Practice, which seeks to ensure that the promotion of medicines is carried out in a responsible, professional and ethical manner,has been published by the Association of the British armaceutical Industry (ABPI).
The guide provides a useful summary of the main provisions of the ABPI Code of Practice, which reflects and extends beyond the legal requirements controlling the advertising of medicines.
“The ABPI Code of Practice has long been recognised throughout the world as the gold standard for other, similar systems of self-regulation. This new guide provides a useful summary of the key points of the code, and will thus be a valuable aid to healthcare managers and professionals,” said Andrew Curl, Deputy Director General of the ABPI.
“It is very important to ensure that the existence of the code and its main provisions are widely known by our colleagues in the NHS. The code is internationally recognised as a model of self-regulation, and provides our stakeholders with real confidence that we shall conduct our relationship with them in a fair and ethical manner at all times.”
The guide is being distributed to NHS executives and managers as well as to organisations such as the Royal Colleges.
For further information, please contact: ABPI Press Office 020 7747 1410